{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:09:19Z","timestamp":1789520959511,"version":"build-2803163510"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH161"],"award-info":[{"award-number":["ZR2024MH161"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189689","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:15Z","timestamp":1787067675000},"page":"189689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP2 in cancer: a double-edged sword and therapeutic target"],"prefix":"10.1016","volume":"1881","author":[{"given":"Peng","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-5205","authenticated-orcid":false,"given":"Hu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-8757","authenticated-orcid":false,"given":"Yingli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-7474","authenticated-orcid":false,"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul","year":"2017","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications \u2014 cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0015","article-title":"Chemical proteomics approaches for protein post-translational modification studies","volume":"1872","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2174\/1871520617666170327110712","article-title":"Post-transcriptional and post-translational regulation of central carbon metabolic enzymes in cancer","volume":"17","author":"Wang","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0040","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/plcell\/koae129","article-title":"Erasing marks: functions of plant deubiquitylating enzymes in modulating the ubiquitin code","volume":"36","author":"Vogel","year":"2024","journal-title":"Plant Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-020-00237-y","article-title":"Emerging functions of branched ubiquitin chains","volume":"7","author":"French","year":"2021","journal-title":"Cell Discov."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061579","article-title":"Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics","volume":"12","author":"Antao","year":"2020","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189689_bb0055","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","article-title":"Deubiquitinases in cancer: new functions and therapeutic options","volume":"31","author":"Fraile","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molcel.2018.02.023","article-title":"Discovery and characterization of ZUFSP\/ZUP1, a distinct deubiquitinase class important for genome stability","volume":"70","author":"Kwasna","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","article-title":"MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes","volume":"63","author":"Abdul Rehman","year":"2016","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189689_bb0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(02)01199-6","article-title":"Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde","volume":"111","author":"Hu","year":"2002","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090848","article-title":"Ubiquitin-specific proteases: players in cancer cellular processes","volume":"14","author":"Cruz","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.trecan.2025.02.004","article-title":"Protease regulation of tumor-immune cell symbiosis","volume":"11","author":"Pang","year":"2025","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.32604\/oncologie.2022.021705","article-title":"Ubiquitin specific protease 2: structure, isoforms, cellular function, related diseases and its inhibitors","volume":"24","author":"Luo","year":"2022","journal-title":"Oncologie"},{"issue":"41","key":"10.1016\/j.bbcan.2026.189689_bb0090","doi-asserted-by":"crossref","first-page":"25560","DOI":"10.1074\/jbc.272.41.25560","article-title":"Molecular cloning of a novel ubiquitin-specific protease, UBP41, with isopeptidase activity in chick skeletal muscle","volume":"272","author":"Baek","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1535-6108(04)00055-8","article-title":"The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer","volume":"5","author":"Graner","year":"2004","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3727\/000000003108749053","article-title":"Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69","volume":"11","author":"Gousseva","year":"2003","journal-title":"Gene Expr."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/db11-0970","article-title":"Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11\u03b2-hydroxysteroid dehydrogenase 1","volume":"61","author":"Molusky","year":"2012","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189689_bb0110","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1096\/fj.13-233528","article-title":"Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation","volume":"27","author":"Kitamura","year":"2013","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1440-1827.2010.02496.x","article-title":"Expression of USP2-69 in mesangial cellsin vivoandin vitro","volume":"60","author":"Wang","year":"2010","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102752","article-title":"Deubiquitinase USP2 stabilizes the MRE11\u2013RAD50\u2013NBS1 complex at DNA double-strand break sites by counteracting the ubiquitination of NBS1","volume":"299","author":"Kim","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0125","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.celrep.2018.02.007","article-title":"USP2a supports metastasis by tuning TGF-\u03b2 signaling","volume":"22","author":"Zhao","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013498","article-title":"CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy","volume":"14","author":"Yan","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0135","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1038\/s41598-025-87151-z","article-title":"MYH9 promotes malignant progression of glioma cells through regulating \u03b2-catenin stability via epithelial-mesenchymal transition signaling pathway","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189689_bb0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/jcmm.16162","article-title":"Ubiquitin-specific protease 2 regulates Ang II-induced cardiac fibroblasts activation by up-regulating cyclin D1 and stabilizing \u03b2-catenin in vitro","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189689_bb0145","article-title":"Decreased USP2a expression inhibits trophoblast invasion and associates with recurrent miscarriage","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12872-024-03748-8","article-title":"Mycn ameliorates cardiac hypertrophy-induced heart failure in mice by mediating the USP2\/JUP\/Akt\/\u03b2-catenin cascade","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0155","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.emboj.7601567","article-title":"The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2","volume":"26","author":"Stevenson","year":"2007","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/onc.2009.330","article-title":"MdmX is a substrate for the deubiquitinating enzyme USP2a","volume":"29","author":"Allende-Vega","year":"2009","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0165","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41467-023-37617-3","article-title":"Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy","volume":"14","author":"Yi","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189689_bb0170","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","article-title":"USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1","volume":"30","author":"Kuang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189689_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217020","article-title":"The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7\u2013H4 in lung adenocarcinoma harboring EGFR-activating mutants","volume":"596","author":"Lu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0180","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-025-59621-5","article-title":"USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity","volume":"16","author":"Dai","year":"2025","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189689_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells14151223","article-title":"Exploiting TCR repertoire analysis to select therapeutic TCRs for cancer immunotherapy","volume":"14","author":"Dema\u00ebl","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13238-012-2120-8","article-title":"USP2a positively regulates TCR-induced NF-\u03baB activation by bridging MALT1-TRAF6","volume":"4","author":"Li","year":"2012","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189689_bb0195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41422-025-01194-5","article-title":"Targeted destruction of VISTA boosts anti-tumor immunotherapy","volume":"35","author":"Chen","year":"2025","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189689_bb0200","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.tcb.2023.10.007","article-title":"Cancer takes many paths through G1\/S","volume":"34","author":"Knudsen","year":"2024","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molcel.2009.10.018","article-title":"Suppression of cancer cell growth by promoting cyclin D1 degradation","volume":"36","author":"Shan","year":"2009","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4161\/cc.11.6.19550","article-title":"The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer","volume":"11","author":"Kim","year":"2012","journal-title":"Cell Cycle"},{"issue":"45","key":"10.1016\/j.bbcan.2026.189689_bb0215","doi-asserted-by":"crossref","first-page":"38960","DOI":"10.1074\/jbc.M111.231498","article-title":"Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A","volume":"286","author":"Shi","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4746","key":"10.1016\/j.bbcan.2026.189689_bb0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0225","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCRESAHA.115.307298","article-title":"The deubiquitylase USP2 regulates the LDLR pathway by counteracting the E3-ubiquitin ligase IDOL","volume":"118","author":"Nelson","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0230","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-025-01589-2","article-title":"USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPAR\u03b3","volume":"33","author":"Luo","year":"2025","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0235","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012721","article-title":"USP2-mediated PPAR\u03b3 stabilization promotes hepatocellular carcinoma progression and M2 macrophage polarization via oleic acid","volume":"13","author":"Cao","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0245","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/med4.44","article-title":"Uncommon\/rare oncogenic drivers in non-small cell lung cancer: consensus and contention","volume":"1","author":"Wu","year":"2023","journal-title":"Med. Adv."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1525216","article-title":"USP2 inhibits lung cancer pathogenesis by reducing ARID2 protein degradation via ubiquitination","volume":"2022","author":"Zhu","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101109","article-title":"USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates","volume":"297","author":"Zhang","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0265","first-page":"39","article-title":"USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC","volume":"18","author":"Gong","year":"2025","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189689_bb0275","first-page":"4746","article-title":"Dysregulation and activities of ubiquitin specific peptidase 2b in the pathogenesis of hepatocellular carcinoma","volume":"11","author":"Nadolny","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189689_bb0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13402-020-00568-8","article-title":"Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A","volume":"44","author":"Xiong","year":"2020","journal-title":"Cell. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0285","first-page":"2392","article-title":"Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0290","first-page":"2206","article-title":"Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress-related autophagy in hepatocellular carcinoma","volume":"40","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0295","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1074\/jbc.M803533200","article-title":"Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-\u03b1-induced hepatocyte survival","volume":"284","author":"Haimerl","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0300","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2024.01.025","article-title":"Dual inhibition of CDK4\/6 and XPO1 induces senescence with acquired vulnerability to CRBN-based PROTAC drugs","volume":"166","author":"Wang","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0305","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41419-025-07977-3","article-title":"DCAF7 recruits USP2 to facilitate hepatocellular carcinoma progression by suppressing clockophagy-induced ferroptosis","volume":"16","author":"Jiang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.21037\/atm.2020.02.141","article-title":"Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression","volume":"8","author":"Meng","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189689_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612816","article-title":"Inhibition of USP2 enhances TRAIL-mediated cancer cell death through downregulation of survivin","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189689_bb0320","doi-asserted-by":"crossref","first-page":"1522392","DOI":"10.3389\/fimmu.2024.1522392","article-title":"Targeting glycolysis: exploring a new frontier in glioblastoma therapy","volume":"15","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189689_bb0325","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41388-022-02275-0","article-title":"Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-\u03b2 signaling","volume":"41","author":"Tu","year":"2022","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189689_bb0330","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/carcin\/bgu015","article-title":"Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma","volume":"35","author":"Wang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"26","key":"10.1016\/j.bbcan.2026.189689_bb0335","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41388-024-03050-z","article-title":"Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis","volume":"43","author":"Song","year":"2024","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0340","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","article-title":"The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma","volume":"19","author":"Niu","year":"2022","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189689_bb0345","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0350","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41419-024-07168-6","article-title":"VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0355","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-019-0451-7","article-title":"Human MLL\/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL\u2013USP2 fusions","volume":"33","author":"Meyer","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0360","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","article-title":"Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure","volume":"32","author":"de Th\u00e9","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0365","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3724\/abbs.2025135","article-title":"Targeting USP2 induces degradation of PML-RAR\u03b1 with or without drug-resistant mutations in acute promyelocytic leukemia","volume":"58","author":"Zhang","year":"2025","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0370","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41467-021-22125-z","article-title":"The origins and genetic interactions of KRAS mutations are allele- and tissue-specific","volume":"12","author":"Cook","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189689_bb0375","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1016\/j.apsb.2024.08.019","article-title":"Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0380","doi-asserted-by":"crossref","first-page":"9263","DOI":"10.1007\/s00432-023-04855-3","article-title":"USP2 promotes cell proliferation and metastasis in choroidal melanoma via stabilizing Snail","volume":"149","author":"Wei","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0385","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41418-020-0538-8","article-title":"The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41419-019-1512-6","article-title":"Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy","volume":"10","author":"He","year":"2019","journal-title":"Cell Death Dis."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2026.189689_bb0395","article-title":"A mini-overview of antibody-drug conjugates in platinum-resistant ovarian cancer: a preclinical and clinical perspective","volume":"304","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2026.189689_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110193","article-title":"Pharmacological USP2 targeting suppresses ovarian cancer growth by potentiating apoptosis and ferroptosis","volume":"762","author":"Yang","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189689_bb0405","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1158\/0008-5472.CAN-06-1374","article-title":"The isopeptidase USP2a protects human prostate cancer from apoptosis","volume":"66","author":"Priolo","year":"2006","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189689_bb0410","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0415","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/2159-8290.CD-11-0219","article-title":"MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer","volume":"2","author":"Benassi","year":"2012","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0420","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1038\/cddis.2013.289","article-title":"USP2a alters chemotherapeutic response by modulating redox","volume":"4","author":"Benassi","year":"2013","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0425","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jb\/mvv039","article-title":"Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP","volume":"158","author":"Mizutani","year":"2015","journal-title":"J. Biochem."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189689_bb0430","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0435","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41388-021-02112-w","article-title":"Tight junction protein 1 promotes vasculature remodeling via regulating USP2\/TWIST1 in bladder cancer","volume":"41","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189689_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102104","article-title":"The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression","volume":"49","author":"Xu","year":"2024","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189689_bb0445","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"47","key":"10.1016\/j.bbcan.2026.189689_bb0450","doi-asserted-by":"crossref","first-page":"24628","DOI":"10.1074\/jbc.M116.738567","article-title":"Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models","volume":"291","author":"Davis","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0455","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00280-021-04348-5","article-title":"EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer","volume":"88","author":"Xiao","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10565-025-10084-w","article-title":"Targeting Skp2 by Tanshinone IIA overcomes chemoresistance in colorectal cancer","volume":"41","author":"Dong","year":"2025","journal-title":"Cell Biol. Toxicol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189689_bb0465","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189689_bb0470","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1080\/15548627.2022.2044651","article-title":"Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression","volume":"18","author":"Xiao","year":"2022","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189689_bb0475","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1110\/ps.083450408","article-title":"Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities","volume":"17","author":"Nicholson","year":"2008","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189689_bb0480","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4161\/cc.20174","article-title":"Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes","volume":"11","author":"Issaenko","year":"2012","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189689_bb0485","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ange.201408411","article-title":"Harnessing the oxidation susceptibility of deubiquitinases for inhibition with small molecules","volume":"127","author":"Ohayon","year":"2015","journal-title":"Angew. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0490","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-026-04321-2","article-title":"Downregulation of B7-H4 contributes to the synergistic effect of USP2a-targeted\/anti-PD-1 combination therapy in EGFR mutant lung cancer","volume":"75","author":"Sun","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0495","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/0113892037334325241014053319","article-title":"PPA1, TRIM68 and FBXO46: potential therapeutic targets for triple negative breast cancer","volume":"26","author":"Haider","year":"2025","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0500","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41419-026-08923-7","article-title":"USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer","volume":"17","author":"Fang","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189689_bb0505","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmech.2018.03.009","article-title":"Identification of small-molecule inhibitors of USP2a","volume":"150","author":"Tomala","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189689_bb0510","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijbiomac.2021.02.072","article-title":"Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21","volume":"176","author":"Lin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0515","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41598-018-21476-w","article-title":"6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2","volume":"8","author":"Chuang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189689_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.749661","article-title":"The inhibitory effects of 6-thioguanine and 6-mercaptopurine on the USP2a target fatty acid synthase in human submaxillary carcinoma cells","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189689_bb0525","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cbic.201800612","article-title":"Halogen substituents in the isoquinoline scaffold switches the selectivity of inhibition between USP2 and USP7","volume":"20","author":"Vamisetti","year":"2019","journal-title":"ChemBioChem"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189689_bb0530","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chembiol.2017.03.002","article-title":"Lithocholic acid hydroxyamide destabilizes cyclin D1 and induces G0\/G1 arrest by inhibiting deubiquitinase USP2a","volume":"24","author":"Magiera","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0535","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101914RR","article-title":"Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1","volume":"36","author":"Zhu","year":"2022","journal-title":"FASEB J."},{"issue":"725","key":"10.1016\/j.bbcan.2026.189689_bb0540","doi-asserted-by":"crossref","first-page":"eadh7668","DOI":"10.1126\/scitranslmed.adh7668","article-title":"USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice","volume":"15","author":"Dang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189689_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107376","article-title":"Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease","volume":"89","author":"Mirza","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189689_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116275","article-title":"The discovery of potent USP2\/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364","volume":"268","author":"Tian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189689_bb0555","first-page":"773","article-title":"Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPAR\u03b3","volume":"74","author":"Yang","year":"2025","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189689_bb0560","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1538\/expanim.25-0032","article-title":"Suppression of USP2 in mouse skeletal muscle: a model of oxidative stress in muscle tissue","volume":"75","author":"Fujimoto","year":"2026","journal-title":"Exp. Anim."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189689_bb0565","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1111\/bph.17311","article-title":"The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination","volume":"181","author":"Zhao","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189689_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102139","article-title":"Deubiquitinating enzyme USP2 regulates brown adipose tissue thermogenesis via controlling EBF2 stabilization","volume":"96","author":"Xu","year":"2025","journal-title":"Mol. Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:26:26Z","timestamp":1789518386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001617"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189689","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP2 in cancer: a double-edged sword and therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189689"}}